Back
Karyopharm Therapeutics Vs. Actinium Pharmaceuticals Industry Stock Comparison
Buy
60
KPTI
Karyopharm Therapeutics
Last Price:
1.14
Seasonality Move:
-4.13%
Buy
56
ATNM
Actinium Pharmaceuticals
Last Price:
9.75
Seasonality Move:
8.57%
Buy
60
Karyopharm Therapeutics (KPTI)
is a Buy
Is Karyopharm Therapeutics a Buy, Sell or Hold?
- The current Karyopharm Therapeutics [KPTI] share price is $1.13. The Score for KPTI is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- KPTI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Actinium Pharmaceuticals (ATNM)
is a Buy
Is Actinium Pharmaceuticals a Buy, Sell or Hold?
- The current Actinium Pharmaceuticals [ATNM] share price is $9.73. The Score for ATNM is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- ATNM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KPTI Stock Price Chart
What is Karyopharm Therapeutics's stock price today?
-
The Karyopharm Therapeutics share price today is $1.13
The current trend is relatively stagnant and KPTI is experiencing slight selling pressure.
ATNM Stock Price Chart
What is Actinium Pharmaceuticals's stock price today?
-
The Actinium Pharmaceuticals share price today is $9.73
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATNM is experiencing selling pressure, which indicates risk of future bearish movement.
KPTI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 48.47 | Sell |
| Chaikin Money Flow: | -263435 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.04 - 1.22) | Sell |
| Bollinger Bands (100): | (0.92 - 1.4) | Sell |
ATNM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.42 | Buy |
| Relative Strength Index (14 RSI): | 66.1 | Buy |
| Chaikin Money Flow: | -248728 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.12 - 9.1) | Buy |
| Bollinger Bands (100): | (5.46 - 8.5) | Buy |
KPTI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.1 | Buy |
| 20-day SMA: | 1.1 | Buy |
| 50-day SMA: | 1.27 | Sell |
| 200-day SMA: | 1.14 | Sell |
| 8-day EMA: | 1.1 | Buy |
| 20-day EMA: | 1.13 | Buy |
| 50-day EMA: | 1.18 | Sell |
| 200-day EMA: | 1.43 | Sell |
ATNM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.06 | Buy |
| 20-day SMA: | 8.06 | Buy |
| 50-day SMA: | 8.1 | Buy |
| 200-day SMA: | 6.33 | Buy |
| 8-day EMA: | 9.09 | Buy |
| 20-day EMA: | 8.55 | Buy |
| 50-day EMA: | 8 | Buy |
| 200-day EMA: | 7.07 | Buy |
Karyopharm Therapeutics Earnings Growth & KPTI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.02 per share, and an increase next year of $0.34 per share.
Actinium Pharmaceuticals Earnings Growth & ATNM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.46 per share, an increase this year of $0.45 per share, and an increase next year of $1.05 per share.
Karyopharm Therapeutics Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Actinium Pharmaceuticals Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||